Ratings by Craig-Hallum (Bill Bonello)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/16/2026 | CareDx, Inc | CDNA | Maintain | Buy (N/A) |
|
Details | ||
| 6/4/2026 | Sera Prognostics Inc | SERA | New Coverage | Buy (N/A) |
2.05 (2.05) |
0% | Details | |
| 5/5/2026 | GeneDx | WGS | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2026 | Strata Critical Medical, Inc. | SRTA | New Coverage | Buy (N/A) |
4.31 (5.15) |
19.49% | Details | |
| 2/12/2026 | Quidel Corp. | QDEL | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2026 | CareDx, Inc | CDNA | Downgrade | Hold (Buy) |
19.81 (39.73) |
100.56% | Details | |
| 11/21/2025 | Exact Sciences | EXAS | Downgrade | Hold (Buy) |
100.67 (104.91) |
4.21% | Details | |
| 10/29/2025 | GeneDx | WGS | Maintain | Buy (N/A) |
|
Details | ||
| 9/11/2025 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 6/27/2025 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2025 | Biodesix | BDSX | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2024 | Akoya Biosciences Inc | AKYA | Downgrade | Hold (Buy) |
3.13 (1.29) |
-58.79% | Details | |
| 10/30/2024 | GeneDx | WGS | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2024 | GeneDx | WGS | Maintain | Buy (N/A) |
|
Details | ||
| 9/5/2024 | Quidel Corp. | QDEL | Upgrade | Buy (Hold) |
40.36 (17.38) |
-56.94% | Details | |
| 8/6/2024 | Akoya Biosciences Inc | AKYA | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2024 | GeneDx | WGS | Maintain | Buy (N/A) |
|
Details | ||
| 7/26/2024 | Biodesix | BDSX | New Coverage | Buy (N/A) |
1.66 (20.19) |
1116.27% | Details | |
| 7/10/2024 | GeneDx | WGS | New Coverage | Buy (N/A) |
29.81 (63.48) |
112.95% | Details | |
| 6/21/2024 | Akoya Biosciences Inc | AKYA | New Coverage | Buy (N/A) |
2.23 (1.29) |
-42.15% | Details | |
| 4/12/2024 | Cerus | CERS | New Coverage | Buy (N/A) |
1.70 (3.13) |
84.12% | Details |
